CNKR3_HUMAN - dbPTM
CNKR3_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID CNKR3_HUMAN
UniProt AC Q6P9H4
Protein Name Connector enhancer of kinase suppressor of ras 3
Gene Name CNKSR3
Organism Homo sapiens (Human).
Sequence Length 555
Subcellular Localization Cytoplasm . Apical cell membrane
Peripheral membrane protein .
Protein Description Involved in transepithelial sodium transport. Regulates aldosterone-induced and epithelial sodium channel (ENaC)-mediated sodium transport through regulation of ENaC cell surface expression. Acts as a scaffold protein coordinating the assembly of an ENaC-regulatory complex (ERC)..
Protein Sequence MEPVTKWSPKQVVDWTRGLDDCLQQYVHKFEREKINGEQLLQISHQDLEELGVTRIGHQELVLEAVDLLCALNYGLETDNMKNLVLKLRASSHNLQNYISSRRKSPAYDGNTSRKAPNEFLTSVVELIGAAKALLAWLDRAPFTGITDFSVTKNKIIQLCLDLTTTVQKDCFVAEMEDKVLTVVKVLNGICDKTIRSTTDPVMSQCACLEEVHLPNIKPGEGLGMYIKSTYDGLHVITGTTENSPADRSQKIHAGDEVIQVNQQTVVGWQLKNLVKKLRENPTGVVLLLKKRPTGSFNFTPAPLKNLRWKPPLVQTSPPPATTQSPESTMDTSLKKEKSAILDLYIPPPPAVPYSPRDENGSFVYGGSSKCKQPLPGPKGSESPNSFLDQESRRRRFTIADSDQLPGYSVETNILPTKMREKTPSYGKPRPLSMPADGNWMGIVDPFARPRGHGRKGEDALCRYFSNERIPPIIEESSSPPYRFSRPTTERHLVRGADYIRGSRCYINSDLHSSATIPFQEEGTKKKSGSSATKSSSTEPSLLVSWFTRLKLLTH
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
8PhosphorylationMEPVTKWSPKQVVDW
CCCCCCCCHHHHHHH
24.6324719451
34UbiquitinationVHKFEREKINGEQLL
HHHHHHHHCCHHHHE
47.9329967540
105PhosphorylationYISSRRKSPAYDGNT
HHHHCCCCCCCCCCC
16.98-
113PhosphorylationPAYDGNTSRKAPNEF
CCCCCCCCCCCCHHH
35.47-
225UbiquitinationKPGEGLGMYIKSTYD
CCCCCCCEEEEEECC
3.622189047
244PhosphorylationITGTTENSPADRSQK
EEECCCCCCCCHHHC
18.4221082442
280UbiquitinationNLVKKLRENPTGVVL
HHHHHHHHCCCEEEE
77.3727667366
283PhosphorylationKKLRENPTGVVLLLK
HHHHHCCCEEEEEEE
54.9418491316
290UbiquitinationTGVVLLLKKRPTGSF
CEEEEEEECCCCCCC
46.8627667366
291PhosphorylationGVVLLLKKRPTGSFN
EEEEEEECCCCCCCC
64.6832645325
294PhosphorylationLLLKKRPTGSFNFTP
EEEECCCCCCCCCCC
49.8728857561
295UbiquitinationLLKKRPTGSFNFTPA
EEECCCCCCCCCCCC
32.6821890473
300UbiquitinationPTGSFNFTPAPLKNL
CCCCCCCCCCCCCCC
21.4622817900
300PhosphorylationPTGSFNFTPAPLKNL
CCCCCCCCCCCCCCC
21.4625159151
305UbiquitinationNFTPAPLKNLRWKPP
CCCCCCCCCCCCCCC
53.5322817900
310UbiquitinationPLKNLRWKPPLVQTS
CCCCCCCCCCCEECC
30.2622817900
322PhosphorylationQTSPPPATTQSPEST
ECCCCCCCCCCCCHH
31.0127732954
323PhosphorylationTSPPPATTQSPESTM
CCCCCCCCCCCCHHC
29.2025850435
325PhosphorylationPPPATTQSPESTMDT
CCCCCCCCCCHHCCC
28.6625850435
328PhosphorylationATTQSPESTMDTSLK
CCCCCCCHHCCCCCC
32.2027732954
329PhosphorylationTTQSPESTMDTSLKK
CCCCCCHHCCCCCCH
19.8727732954
332PhosphorylationSPESTMDTSLKKEKS
CCCHHCCCCCCHHHC
25.7428857561
333PhosphorylationPESTMDTSLKKEKSA
CCHHCCCCCCHHHCC
33.6528857561
339PhosphorylationTSLKKEKSAILDLYI
CCCCHHHCCEEEEEC
22.9528348404
355PhosphorylationPPPAVPYSPRDENGS
CCCCCCCCCCCCCCC
13.8519276368
362PhosphorylationSPRDENGSFVYGGSS
CCCCCCCCEEECCCC
24.1128857561
365PhosphorylationDENGSFVYGGSSKCK
CCCCCEEECCCCCCC
17.48-
368PhosphorylationGSFVYGGSSKCKQPL
CCEEECCCCCCCCCC
23.4328857561
381PhosphorylationPLPGPKGSESPNSFL
CCCCCCCCCCCCCCC
40.8123401153
383PhosphorylationPGPKGSESPNSFLDQ
CCCCCCCCCCCCCCH
30.9529255136
386PhosphorylationKGSESPNSFLDQESR
CCCCCCCCCCCHHHH
30.4830266825
392PhosphorylationNSFLDQESRRRRFTI
CCCCCHHHHHCCEEE
26.0023403867
398PhosphorylationESRRRRFTIADSDQL
HHHHCCEEECCCCCC
17.2820736484
408PhosphorylationDSDQLPGYSVETNIL
CCCCCCCCEEECCCC
13.9627642862
425PhosphorylationKMREKTPSYGKPRPL
CCCCCCCCCCCCCCC
52.3124719451
426PhosphorylationMREKTPSYGKPRPLS
CCCCCCCCCCCCCCC
30.30-
433PhosphorylationYGKPRPLSMPADGNW
CCCCCCCCCCCCCCC
25.9622617229
464PhosphorylationGEDALCRYFSNERIP
CHHHHHHHHCCCCCC
15.4628857561
466PhosphorylationDALCRYFSNERIPPI
HHHHHHHCCCCCCCC
28.9327422710
472PhosphorylationFSNERIPPIIEESSS
HCCCCCCCCCCCCCC
37.5132645325
477PhosphorylationIPPIIEESSSPPYRF
CCCCCCCCCCCCCCC
24.2729978859
478PhosphorylationPPIIEESSSPPYRFS
CCCCCCCCCCCCCCC
50.5821815630
479PhosphorylationPIIEESSSPPYRFSR
CCCCCCCCCCCCCCC
38.8925850435
482PhosphorylationEESSSPPYRFSRPTT
CCCCCCCCCCCCCCC
27.8927251275
483MethylationESSSPPYRFSRPTTE
CCCCCCCCCCCCCCC
28.92-
485PhosphorylationSSPPYRFSRPTTERH
CCCCCCCCCCCCCHH
28.4923403867
488PhosphorylationPYRFSRPTTERHLVR
CCCCCCCCCCHHHHC
39.9323403867
489PhosphorylationYRFSRPTTERHLVRG
CCCCCCCCCHHHHCC
33.4323403867
495MethylationTTERHLVRGADYIRG
CCCHHHHCCCCCCCC
40.73-
503PhosphorylationGADYIRGSRCYINSD
CCCCCCCCCEEECCC
14.8827470641
506PhosphorylationYIRGSRCYINSDLHS
CCCCCCEEECCCCCC
11.3028152594
514PhosphorylationINSDLHSSATIPFQE
ECCCCCCCCEECCCC
20.77-
537PhosphorylationSSATKSSSTEPSLLV
CCCCCCCCCCHHHHH
43.8322210691
545PhosphorylationTEPSLLVSWFTRLKL
CCHHHHHHHHHHHHH
19.22-

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of CNKR3_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of CNKR3_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of CNKR3_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
RHG39_HUMANARHGAP39physical
28514442
VCIP1_HUMANVCPIP1physical
28514442
DIP2B_HUMANDIP2Bphysical
28514442
GT252_HUMANCOLGALT2physical
28514442
NISCH_HUMANNISCHphysical
28514442

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of CNKR3_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-383, AND MASSSPECTROMETRY.

TOP